Literature DB >> 18184347

Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation.

M Janghorbani1, M Zare, M Saadatnia, S A Mousavi, M Mojarrad, E Asgari.   

Abstract

OBJECTIVE: To estimate the frequency of cerebral vein and dural sinus thrombosis (CVST) and its seasonal variation.
METHODS: A clinic-based prospective case-register study was conducted from 2001 to 2004. Hundred and twenty-two consecutive definite CVST patients (26 men and 96 women) treated in two major neurological centres of Isfahan, Iran, were included in the study. Part of examination included an assessment of CVST including conventional angiography and/or magnetic resonance imaging and self-reported medical history. Population data were obtained from the 1996 Iran Census. The mean (standard deviation) age of participants was 35.5 (11.9) years.
RESULTS: The annual frequency (95% confidence interval) of CVST was 12.3 (10.1, 14.5) per million in a population of 2,472,751, with higher rate in women than in men [19.9 (15.5, 23.9) women and 5.1 (3.2, 7.1) men] and with increasing age in women (up to 50 years), but not in men. The female/male ratio was 3.9 (2.5-6.0). The monthly frequency of CVST ranged from 0.6 per million (0.1, 1.1) in August to 2.1 (1.2, 3.0) in September. The seasonal CVST rate ranged from 2.2 per million (1.3, 3.2) in summer to 4.3 (3.1, 5.7) in autumn. The differences were statistically significant either for the months or season (P < 0.05).
CONCLUSION: The findings of this study show the CVST frequency in adults. More women than men are present with CVST and its frequency increased during autumn.

Entities:  

Mesh:

Year:  2008        PMID: 18184347     DOI: 10.1111/j.1600-0404.2007.00915.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  18 in total

1.  Safety and efficacy of the use of large bore intermediate suction catheters alone or in combination for the treatment of acute cerebral venous sinus thrombosis: A multicenter experience.

Authors:  Sudeepta Dandapat; Edgar A Samaniego; Viktor Szeder; Fazeel M Siddiqui; Gary R Duckwiler; Ume Kiddy; Waldo R Guerrero; Binbin Zheng; David Hasan; Colin Derdeyn; Santiago Ortega-Gutierrez
Journal:  Interv Neuroradiol       Date:  2019-07-31       Impact factor: 1.610

2.  Low levels of tissue factor pathway inhibitor increase the risk of cerebral venous thrombosis.

Authors:  Shaghayegh Haghjooy Javanmard; Tayebeh Shahsavarzadeh; Mohammad Saadatnia
Journal:  Adv Biomed Res       Date:  2015-01-06

Review 3.  Cerebral venous thrombosis.

Authors:  Suzanne M Silvis; Diana Aguiar de Sousa; José M Ferro; Jonathan M Coutinho
Journal:  Nat Rev Neurol       Date:  2017-08-18       Impact factor: 42.937

4.  Trends in incidence and epidemiologic characteristics of cerebral venous thrombosis in the United States.

Authors:  Fadar Oliver Otite; Smit Patel; Richa Sharma; Pushti Khandwala; Devashish Desai; Julius Gene Latorre; Emmanuel Oladele Akano; Nnabuchi Anikpezie; Saef Izzy; Amer M Malik; Dileep Yavagal; Priyank Khandelwal; Seemant Chaturvedi
Journal:  Neurology       Date:  2020-08-26       Impact factor: 9.910

5.  A Prospective Study of the Clinical Profile, Outcome and Evaluation of D-dimer in Cerebral Venous Thrombosis.

Authors:  Venkatesh Thammishetti; Subrahmanyam Dharanipragada; Debdatta Basu; Ramesh Ananthakrishnan; Deepanjali Surendiran
Journal:  J Clin Diagn Res       Date:  2016-06-01

6.  Advances in the treatment of cerebral venous thrombosis.

Authors:  J M Coutinho; S Middeldorp; J Stam
Journal:  Curr Treat Options Neurol       Date:  2014-07       Impact factor: 3.598

7.  Cerebral venous sinus thrombosis in iran: cumulative data, shortcomings and future directions.

Authors:  Afshin Borhani Haghighi; Nahid Ashjazadeh; Anahid Safari; Salvador Cruz-Flores
Journal:  Iran Red Crescent Med J       Date:  2012-12-06       Impact factor: 0.611

8.  Clinicoepidemiological profile of cerebral venous thrombosis in Algarve, Portugal: A retrospective observational study.

Authors:  Hipólito Nzwalo; Fátima Rodrigues; Patricia Carneiro; Ana Macedo; Fátima Ferreira; Carlos Basílio
Journal:  J Neurosci Rural Pract       Date:  2015 Oct-Dec

9.  Oral contraceptive misuse as a risk factor for cerebral venous and sinus thrombosis.

Authors:  Mohammad Saadatnia; Neda Naghavi; Farzad Fatehi; Mohammad Zare; Marzieh Tajmirriahi
Journal:  J Res Med Sci       Date:  2012-04       Impact factor: 1.852

10.  Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study.

Authors:  Mohammad Saadatnia; Mansour Salehi; Ahmad Movahedian; Seyed Ziaeddin Samsam Shariat; Mehri Salari; Marzieh Tajmirriahi; Elham Asadimobarakeh; Rasoul Salehi; Gilda Amini; Homa Ebrahimi; Ehsan Kheradmand
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.